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Abstract
Diacylglycerol kinase plays a central role in the metabolism of diacylglycerol by converting diacylglycerol into
phosphatidic acid thus initiating resynthesis of phosphatidylinositols. Diacylglycerol is a known second messenger reversibly
activating protein kinase C. In addition, diacylglycerol is a potential precursor for polyunsaturated fatty acids. We describe
the identification and molecular analysis of a novel type III Drosophila diacylglycerol kinase isoform, DGKO. Drosophila
DGKO is mapped to the cytological position 49C1-3. DGKO mRNA is 1.9 kb in length and is broadly distributed throughout
development in different cells, primordia and organs, including testes. In embryogenesis, the transcripts are enriched in the
cells, which are in S-phase or undergoing endoreplication. Comparison of the Drosophila DGKO with the human homologue
revealed that the first zinc finger-like motif is specific for the type III isoform. Although the testis-specific diacylglycerol
kinase activity is dependent upon the dose of DGKO gene, the deletion of DGKO does not modulate the total cellular
diacylglycerol level. In spite of a proposed key role of diacylglycerol kinase in termination of the diacylglycerol signal,
overexpression of a DGKO transgene in flies under the control of a yeast upstream activating sequence promoter does not
disrupt normal development in Drosophila. ß 2001 Elsevier Science B.V. All rights reserved.
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1. Introduction
Diacylglycerol (DG) has a dual function in the
cell. Besides playing an important role in the synthe-
sis of phospholipids, that are structural components
of membranes, it also is a known intracellular second
messenger. Upon binding to the cell surface recep-
tors, many extracellular signaling molecules trans-
duce the signal inside the cell by activating phos-
phatidylinositol-speci¢c phospholipase C (PLC).
Activated PLC then hydrolyzes phosphatidylinositol
4,5-biphosphate to generate inositol 1,4,5-tris-phos-
phate and DG [1], an activator of protein kinase C
(PKC) [2]. The release of inositol 1,4,5-tris-phosphate
is accompanied by the concurrent mobilization of
intracellular calcium. Subsequent events include re-
synthesis of phosphatidylinositols (PI) [3] with the
key role played by diacylglycerol kinase (DGK, EC
2.7.1.107). Stimulated DGK rapidly phosphorylates
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DG to phosphatidic acid (PA). Besides termination
of the signal, the formation of PA has another fun-
damental implication: PA is converted back to PI,
resulting in a PI cycle [4,5]. Thus, by converting DG
to PA, DGK initiates the resynthesis of PI.
Alternatively, DG can be generated from phospha-
tidylcholine (PC) in the phospholipase D pathway. In
a concerted manner, PC are ¢rst hydrolyzed by phos-
pholipase D to form PA that is then converted to
DG by phosphatidic acid phosphohydrolase [5].
DG derived from breakdown of PC is distinct in
its fatty acyl group composition from DG molecules
resulting from hydrolysis of PI. In mammals, PI con-
tains mainly polyunsaturated fatty acids and is en-
riched in 1-stearoyl-2-arachidonoyl-sn-glycerol spe-
cies [6]. On the contrary, PC, which are more
abundant than PI [7], are mostly saturated and
mono-unsaturated. The physiological reason behind
the physical separation of DG species derived from
di¡erent pathways has been recently recognized:
only polyunsaturated DG and saturated or mono-
unsaturated PA can serve as second messengers [8^
10]. It was noted that DG derived from degradation
of PC is a poor substrate for DGK, while DG origi-
nated from PI is rapidly phosphorylated [11]. Inhibi-
tion of DGK activity may result in the production of
a longer-lived DG signal [12]. However, the question
still remains regarding the extent of a DGK role in
the metabolism of DG and therefore regulation of
DG levels. In platelets, DGK phosphorylation repre-
sents the major pathway for metabolism of DG [13].
On the contrary, conversion of DG to monoacylgly-
cerol by DG lipase in cardiac myocytes was several-
fold higher than conversion of DG to PA in the
DGK pathway [14]. A minor contribution of DGK
in the metabolism of DG has been found in several
di¡erent cell types including ¢broblasts, where DG is
preferentially converted to triacylglycerol rather then
to PA [15].
DGK activity is known to exist in a wide variety
of tissues and organisms, from bacteria to human.
Nine mammalian isoforms of DGK have been
cloned and studied: DGKK [16,17], DGKL [18],
DGKQ [19], DGKN [20], DGKR [21], DGKj [22],
DGKa [23], DGKS [24], and DGKO [25]. Except
DGKO, none of these isoforms possess a marked
speci¢city with regard to the acyl compositions of
DG. On the contrary, DGKO exhibits a strong pref-
erence for arachidonate containing DG species [25].
The presence of DGK activity selective for this sub-
strate has been demonstrated in Swiss 3T3 cells [26],
and in bovine [27] and baboon [28] tissues where the
activity was highest in testis followed by brain. Since
DGK initiates the PI cycle, arachidonate-speci¢c ki-
nase might be responsible for maintaining the unique
fatty composition of PI in mammals. One can pre-
sume that multiple cycles of the DGK reaction pref-
erentially producing arachidonoyl-PA will progres-
sively enrich PI with arachidonate [25,26]. Although
a thorough biochemical analysis of mammalian
DGKO isoform has been performed, the role of this
kinase in vivo is unclear.
Drosophila, with extensive genetic and molecular
approaches, provides an excellent model to study
cellular functions of DGK. To date, two di¡erent
DGK genes were identi¢ed in Drosophila. One of
them, retinal degeneration A (rdgA), is implicated in
age-dependent degeneration of photoreceptor cells in
the retina [29,30]. Flies mutant for rdgA have photo-
receptor cells that di¡erentiate normally but degen-
erate rapidly after eclosion. The mutants are defec-
tive in the transport by photoreceptive membranes
presumably due to abnormalities in the supply of
membrane components, in particular phospholipids
[30]. The degeneration starts with the disruption of
the subrhabdomeric cisternae, which are the organ-
elles necessary for the transport of phospholipids to
the membranes. PA, known as an important inter-
mediate in the formation of various phospholipids,
was found to be present at low level in rdgA de¢cient
£ies [29]. It was proposed therefore that loss of the
speci¢c DGK isoform encoded by the rdgA locus
results in lack of PA, since DG is not phosphorylated
into PA in the mutant. Analysis of £ies double mu-
tant for rdgA and the eye-speci¢c protein kinase C
suggests that retinal degeneration is caused by the
lack of PA rather than excessive accumulation of
DG [31].
In a search for modi¢ers of white gene expression,
a P-element induced mutation in the oxen locus [32]
was isolated. During the transcriptional mapping of
the oxen region, we have identi¢ed a gene encoding a
homologue of human DGKO. Despite the abundance
of information on human DGKO, little is known
about the role this kinase plays in the development
of multicellular organisms. Therefore, a functional
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analysis of Drosophila DGKO was further pursued.
Both Drosophila and human isoforms share a unique
¢rst zinc ¢nger-like motif, which is not found in oth-
er proteins. Drosophila DGKO transcripts are present
throughout development and enriched in testes. Tes-
tis-speci¢c diacylglycerol kinase activity correlates
with the dose of the DGKO gene. We did not ¢nd
any indications for DGKO regulation of the cellular
DG levels. A full-size DGKO cDNA under the con-
trol of the yeast upstream activating sequence (UAS)
promoter was transformed into £ies. The ectopic ex-
pression of the DGKO transgene does not interfere
with normal £y development.
2. Materials and methods
2.1. Materials
Radiolabeled nucleotides were from Du Pont-New
England Nuclear. Neutral membrane for RNA trans-
fer and positively charged membrane for DNA trans-
fer were obtained from Qiagen. Restriction enzymes,
T4 DNA ligase and Klenow enzyme were purchased
from New England Biolabs. Diacylglycerol, phos-
phatidic acid and ribonucleotides were from Sigma.
T3 and T7 RNA polymerases and pSP72 vector were
from Promega. RNase inhibitor and digoxigenin
(DIG) RNA labeling mix were obtained from Boehr-
inger-Mannheim. The oligonucleotides were synthe-
sized by Life Technologies. The Sequenase version
2.0 DNA sequencing kit was purchased from Amer-
sham. Escherichia coli diacylglycerol kinase and octyl
L-glucopyranoside were from Calbiochem. Other
chemicals and materials were from Sigma and Fish-
er.
2.2. Fly stocks and P-element transformation
Flies were raised on standard Drosophila medium
at 25‡C. Genetic markers used here can be found in
Lindsley and Zimm [33].
ms(2)00815, a single P-element insertion on chro-
mosome 2 (49C1-4) [34], was identi¢ed in a large
screen for autosomal mutations a¡ecting the eye col-
or of white-apricot £ies. The same insertion was ini-
tially isolated as a male sterile mutation and named
oxen1 (ox1) [32]. To mobilize the P-element, which
has a rosy marker gene, ox1/CyO ; ry506/ry506 males
were crossed to Sp/CyO ; v2-3, Sb/TM6, Ubx strain,
containing a stable source of transposase [35]. The F1
ox1/CyO ; v2-3, Sb/ry506 males were crossed individ-
ually to three Sp/CyO ; ry506/TM6, Ubx females. The
Cy, non-Sb, non-Sp progeny (ox1/CyO ; ry506/ry506)
were screened for rosy3 £ies, which were mated to
Gla/SM6a, Cy balancers to establish a stock. The
loss of the rosy marker gene indicates that the exci-
sion of the P-element occurred.
For P-element transformation, the c1 cDNA con-
taining a full-sized DGKO open reading frame was
cloned into the pUAST vector carrying the mini-
white marker gene [36] to generate P[mw ; UAS-
DGKO]. The construct was injected together with
the wings-clipped helper plasmid into y w embryos
as described [37]. Two transformed lines with
P[mw ; UAS-DGKO] on chromosome 2 were selected
by the mini-white marker gene. The presence of the
transgene was veri¢ed by Southern analysis.
2.3. DNA and RNA manipulation
All standard DNA manipulations were performed
as described [38].
The P1 phage 05-71, containing wild-type DNA
from the 49C1-D3 region on the cytological map
[39], was used to obtain an overlapping set of
DNA fragments for cDNA library screens and se-
quencing.
The fragment £anking the P-element insertion site
was cloned by the ‘plasmid rescue’ method [40]. Ap-
prox. 1 Wg of the genomic DNA was digested with
the enzyme XbaI. After inactivation and dilution, a
ligation reaction was performed in 200 Wl at 16‡C
overnight. The mixture was precipitated and used
for electroporation of E. coli DH5K.
For sequencing, DNA fragments were cloned into
the pSP72 (Promega) or Bluescript II SK (Strata-
gene) vector. To obtain nested clones for sequencing,
a Q-N transposon-based system was used [41]. Manual
sequencing was performed on a Sequi-Gen GT nu-
cleic sequencing cell (Bio-Rad) using the Sequenase
(v.2.0) kit (Amersham). Sequence analysis and multi-
ple alignments were performed using DNA STAR
software (DNASTAR). Homology searches were
performed at the National Center for Biotechnology
Information’s BLAST WWW Server.
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Northern analysis of DGKO expression was per-
formed in segregating populations. For that, ox/
SM6a, Cy females were crossed to wild-type Canton
S males. The Curly marker allows discrimination be-
tween +/+ and ox/+ classes. RNA was isolated from
adult £ies of di¡erent classes according to the meth-
od of Chomczynski and Sacchi [42]. For Northern
analysis, RNA samples were prepared in bu¡er
(20 mM morpholinopropanesulfonic acid (MOPS),
5 mM sodium acetate, 1 mM EDTA) with 2.2 M
formaldehyde and 50% (v/v) deionized formamide
and then heat-denatured for 5 min at 65‡C. The
RNA was fractionated in the above described bu¡er
on 1% agarose gels containing 2.2 M formaldehyde.
The RNA was transferred by capillary blotting in
20USSPE from the gel to neutral nylon membranes
(Qiagen) and then hybridized to radiolabeled anti-
sense RNA probes prepared as described previously
[43]. The prehybridization and hybridization solu-
tions were 0.5 M NaCl, 10% dextran sulfate, 0.2
mg/ml heparin, 1% sarkosyl, 0.1 M sodium phos-
phate (pH 7.0), 0.1% ¢coll, 0.1% polyvinylpyrroli-
done, 0.1% sodium pyrophosphate and 50% (v/v)
formamide. The ¢lters were washed three times in a
solution containing 5 mM sodium phosphate, 0.2%
SDS, and 1 mM EDTA for 1 h at 75‡C.
2.4. Cloning of DGKO cDNA
The cDNA library was prepared from 2 week old
male and female wild-type adults (Canton S) in the
VZAP II vector (Stratagene). About 900 000 phage
have been screened as described [38].
To obtain the 5P end of DGKO, the rapid ampli¢-
cation of cDNA ends (RACE) protocol was per-
formed using the Marathon cDNA Ampli¢cation
Kit (Clontech) according to the manufacturer’s rec-
ommendations. As a template for cDNA synthesis,
the poly(A)RNA was isolated from Canton S adult
£ies using an oligo(dT) cellulose [38]. For polymerase
chain reaction (PCR), the following primer was
used: 5P-GAGATTAGGGACTGGCACATAAGG-
3P. The RACE product, named c1, was directly
cloned into pGEM-T vector (Promega).
2.5. In situ hybridization histochemistry
In situ hybridization was performed essentially as
described [44]. Eye imaginal discs were dissected in
PBT, ¢xed in 3.7% formaldehyde for 30 min, washed
in PBS and treated in 0.5 M EGTA/methanol (1:9)
for 1 min. After rehydration in methanol with PBT,
the discs were incubated for 15 min in 100 Wg/ml
proteinase K in PBS, rinsed in 2 mg/ml glycine in
PBT, washed in PBT, re¢xed in formaldehyde for
20 min and ¢nally washed three times in PBT for
10 min each. Testes and ovaries were treated accord-
ing to Lankenau et al. [45]. Riboprobes were pre-
pared by in vitro transcription with DIG RNA label-
ing mix and detected with alkaline phosphatase
conjugated anti-DIG antibody (Boehringer-Mann-
heim).
2.6. Assay of diacylglycerol kinase activity
Flies were dissected on ice; testes were collected
and frozen in liquid nitrogen. Testes were homoge-
nized in a bu¡er containing 20 mM sodium phos-
phate bu¡er (pH 6.8), 100 mM KCl, 10 mM NaCl,
1 mM EGTA, 20 mg/ml pepstatin and 1 mM phen-
ylmethylsulfonyl £uoride (PMSF) [29]. The activity
of diacylglycerol kinase was determined by measur-
ing the rate of incorporation of [Q-32P]ATP into PA
in a mixed micellar assay [26]. The standard reaction
mixture was carried out in 100 mM KCl, 10 mM
NaCl, 1 mM EGTA, 20 mM phosphate bu¡er (pH
6.8), 10 mM KF, 2 mM DG, 75 mM octyl glucoside,
2 mM [Q-32P]ATP, 20 mg/ml pepstatin, 1 mM PMSF
and tissue homogenate containing 20^50 Wg of pro-
tein. The ¢nal volume of the reaction mixture was
100 Wl. DG was freshly prepared and brie£y soni-
cated using a microtip before addition to the reac-
tion. The reaction was initiated by adding the homo-
genate and carried out for 4 min at room
temperature. Under these conditions, the rate of in-
corporation of labeled phosphate into PA was linear.
The reaction was terminated by the addition of 100
Wl of 1 N HCl. To extract lipids, 25 Wg of phospha-
tidic acid were added as a carrier followed by 250 Wl
of chloroform/methanol (1:1, v/v) and the mixture
was vortexed. The phases were separated by brief
centrifugation and the lower phase was washed twice
with 100 Wl of methanol/0.1 N HCl (1:1, v/v). The
lower phase was dried under vacuum. The lipids were
dissolved in a small volume of chloroform/methanol/
12 N HCl (200:100:0.75, v/v) and separated by thin
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layer chromatography (TLC) on silica gel plates
(Whatman). Ascending chromatography was carried
out with butanol/acetic acid/water (75:10:25) solvent
[26]. After development, the band of 32P labeled PA
was detected by phosphorimagery and by iodine va-
por. The samples were normalized to the amount of
protein that was determined by the Bio-Rad protein
dye assay.
2.7. Measurement of DG levels
Lipids were extracted as described [46]. Brie£y, 100
Wl of testis homogenate was extracted with 1 ml
chloroform:methanol (1:2, v/v). Su⁄cient 1 M
NaCl was added to bring the aqueous volume to
0.25 ml. The monophase was mixed, 0.3 ml of
chloroform and 0.3 ml of 1 M NaCl were then added
to break the phases. After centrifugation at 5000Ug
for 2 min, the lower phase was dried. The pellet
containing total lipids was resuspended in 50 Wl of
chloroform. To measure the amount of DG in the
sample, the method developed by Preiss et al. [47]
was used. The assay is based on the ability of E.
coli DGK to quantitatively convert DG to PA in
the presence of [Q-32P]ATP. The products of the re-
action were separated by TLC as described above.
The lipids from the mutant and revertant testes
were extracted and analyzed in parallel, using the
same batch of E. coli DGK enzyme (Calbiochem).
2.8. Overexpression of DGKO in E. coli
To optimize DGKO sequences for expression in a
QIAexpress-type construct (Qiagen), the translation
start codon was removed by PCR using the synthetic
primer 5P-GGCATGCGGACATAGGCACTATCG-
3P on the RACE generated cDNA clone c1. The
PCR product was cloned in pGEM-T vector (Prom-
ega). The 0.48 kb SphI-NcoI fragment from the PCR
product was fused with 1.2 kb NcoI-SalI fragment of
c1. The resulting SphI-SalI fragment containing the
initiator methionine followed by the full-size open
reading frame was cloned into the corresponding
sites of the expression vector pQE32 (Qiagen) to cre-
ate pQE-DGK. Thus, pQE-DGK contains the DGKO
coding sequence together with 6UHis a⁄nity tag.
For negative control, the same SphI-SalI fragment
was cloned in the pQE31 vector to create pQE-c-
DGK, which has a frameshift in the open reading
frame.
Both plasmids were transformed into E. coli strain
M15[pREP4]. For induction, an overnight culture
was grown at 30‡C to an A600 of 0.7^0.8. An aliquot
of culture with pQE-DGK plasmid was removed pri-
or to induction with IPTG (0.5 mM IPTG ¢nal con-
centration) and growth was resumed for 1^2 h. The
following steps were performed at 4‡C. Bacteria were
harvested at 4000Ug and resuspended in sonication
bu¡er (50 mM Na-phosphate pH 8.0, 300 mM NaCl,
1 mg/ml lysozyme). After freezing on dry ice, the
samples were sonicated and incubated with 10 Wg/
ml RNase A and 5 Wg/ml of DNase I for 15 min.
Following the sedimentation of bacterial debris, the
supernatant was removed and used as a source of
crude extract. Protein was puri¢ed in native condi-
tions according to the Qiagen protocol, using 1 mM
PMSF at all steps of puri¢cation. The crude extract
was applied to a Ni-NTA column (1 ml volume). The
protein was eluted with a stepwise gradient of imida-
zole. Fractions were monitored for DGK activity
and protein content.
3. Results
3.1. Molecular cloning of DGKO
The P-element insertion at the cytological position
49C1-4, ms(2)00815 [34], was isolated in a screen for
mutations a¡ecting the eye color of white-apricot
£ies. This P-element insertion has previously been
identi¢ed as a male-sterile mutation and named
oxen1 (ox1) [32]. A fragment of genomic DNA adja-
cent to the P-element insertion site was cloned by the
‘plasmid rescue’ method [40]. This fragment was used
to obtain an overlapping set of genomic DNA frag-
ments from a P1 phage, 05-71 [39]. Probing a cDNA
library with a 0.54 kb PstI-PstI fragment yielded six
di¡erent independent clones. The isolated cDNAs
were further sequenced together with the genomic
fragment. The longest cDNA, 1.8 kb in length, was
found to have an internal rearrangement when com-
pared to the genomic sequence. Because we found a
high proportion of rearranged clones in the library in
our previous screens, we concluded that the 1.8 kb
cDNA is arti¢cial. The fact that no similarly rear-
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ranged cDNA was obtained in the RACE protocol
(see below) supports this conclusion. The other ¢ve
clones were less than 1 kb in length, thus represent-
ing no full-size cDNAs. No di¡erent cDNA clones
were isolated in a subsequent cDNA library screen
using the 1.8 kb cDNA as a probe. Therefore, a
RACE was performed using the primer derived
from the genomic sequence corresponding to the 3P
region of the 1.8 kb cDNA. The composite cDNA
was found to be 1903 bp in length. The 5P end of the
corresponding transcript was unambiguously deter-
mined by the sequencing of the cloned RACE prod-
uct. The P-element in the ox1 allele is inserted 135 bp
upstream from the putative transcription start site
(Fig. 1). The comparison of the cDNA sequence
with the genomic sequence revealed the presence of
three short introns with a size range between 56 and
58 bp.
The composite cDNA has an open reading frame
of 534 amino acids encoding a 70 kDa protein (Fig.
2). The context of the ¢rst initiator methionine co-
don is similar in ¢ve of seven nucleotides to the Cav-
ener consensus sequence (C/A)AA(A/C)ATG for
translation start sites in Drosophila genes [48].
When the sequence of the predicted translation prod-
uct was searched against translated sequences from
GenBank, a strong homology to di¡erent DGKs was
found (Fig. 3). The Drosophila protein is most sim-
ilar to human type III DGKO [24,25] (34.2% overall
identity). More importantly, both DGKs share com-
mon structural features including two cysteine-rich
zinc ¢nger-like motifs (C1) and a catalytic domain
[25]. Thus, the identi¢ed Drosophila protein can be
classi¢ed as a type III DGK [24], and was therefore
named DGKO. More detailed sequence analysis re-
vealed that the ¢rst zinc ¢nger-like motif (residues
His43-Cys95 according to the sequence of Drosophila
DGKO), C-X2-C-X11-C-X2-C-X9-C-X9-C, seems to
be characteristic for the DGKO isozyme (Fig. 3A).
The only di¡erence between the Drosophila and hu-
man ¢rst zinc ¢nger-like motifs is that in Drosophila,
the number of amino acids in the second and fourth
spacings is 11 and nine amino acids instead of nine
and seven amino acids as in human. The second zinc
¢nger-like motif (His108-Cys164), C-X2-C-X18-C-X2-
C-X7-C-X9-C, is more conserved among DGKs. In
addition to human DGKO, similar sequences are
present in hamster DGKR [21], Drosophila DGK en-
coded by the rdgA locus [30] as well as Dictyostelium
heavy chain myosin kinase (HCMK) [49] (Fig. 3B).
The catalytic domain of Drosophila DGKO contains
one ATP binding motif and shows a strong similarity
to the corresponding domain of other DGKs (Fig.
3C). The overall sequence identities of the C4 do-
main of Drosophila DGKO are 39%, 33% and 29%,
respectively, when compared with those of DGKO,
DGKK and DGKR.
3.2. Expression of DGKO in development
First, a deletion of Drosophila DGKO was gener-
ated. We took advantage of the fact that at low
frequency, the excision of the P-element is accompa-
nied by deletion of the genomic sequences outside of
the insertion site. The P-element was mobilized as
described in Section 2 and the genomic structure of
the derivatives was determined by Southern analysis.
In that way, a 0.9 kb deletion, designated as ox107ÿ2,
was generated (Fig. 1). In parallel, the line showing a
precise excision of the P-element, oxrev, was isolated
for further study as a control of normal expression of
the DGKO gene.
Fig. 1. Restriction map of the DGKO gene. Sites for endonu-
cleases EcoRI (E), BamHI (B), NcoI (N) and PstI (P) are
shown. Site of the P[lacZ, rosy] insertion in the ox1 allele is
designated by a triangle. An open box shows the sequences de-
leted in ox107ÿ2 alleles. The positions of the breakpoints in
ox107ÿ2 were determined by Southern analysis. In the DGKO
transcript, non-coding sequences are black. The cDNA c1,
which was generated in the RACE protocol, is shown below.
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To examine the expression of DGKO, a Northern
blot analysis of RNA isolated from £ies segregating
for the ox1, ox107ÿ2 and oxrev alleles was performed.
As shown in Fig. 4, a single transcript 1.9 kb in
length was detected in males and females. The
amount of the transcript is reduced to 80% in the
case of the P-element insertion in ox1 £ies. The ex-
pression of the DGKO mRNA is decreased to one-
half in the deletion, ox107ÿ2, relative to the respective
control and restored to normal in oxrev.
Next we investigated the pattern of DGKO expres-
sion in development by in situ hybridization. In the
oocyte, DGKO transcripts are not seen until stage 9.
At stage 10, a strong staining is observed in nurse
cells (Fig. 5A). During embryogenesis, a subset of
postmitotic cells enter endoreplication cycles where
Fig. 2. Nucleotide and deduced amino acid sequences of the composite DGKO cDNA. The predicted amino acid sequence from the
cDNA is shown. The sequences of the three introns are not shown but their positions and lengths are designated with triangles. The
polyadenylation signal [57] is underlined. The cDNA terminates in a poly(A) tail at the 3P end. The DNA sequence is available in
GenBank under accession No. AF017783.
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they progress through several rounds of S-cycles
without intervening mitosis. As a result, after several
rounds of DNA replication, the endoreplicative cells
become polyploid. Interestingly, DGKO mRNA
expression is enriched in the endoreplicative cells or
in S-phase cells. The yolk nuclei that commence en-
doreplication at mitosis 10 stain densely for DGKO
mRNA (Fig. 6A). The S-phase cells in both ectoderm
and mesoderm reveal a strong staining (Fig. 6C).
Later in development, any domain undergoing en-
doreplication is depicted in the DGKO mRNA pat-
tern. DGKO is expressed in the anterior and posterior
midgut primordia, which begin to endoreplicate dur-
ing germ band retraction (Fig. 6D). A strong staining
is detected in Malpighian tubules and hindgut under-
going endoreplication with dorsal closure (Fig. 6F).
Fig. 3. Sequence similarity between the sequence of Drosophila DGKO and conserved regions in other DGKs. Multiple alignment of
the predicted amino acid sequence of the ¢rst (A) and second (B) zinc ¢nger-like motifs and conservative catalytic domain (C) of Dro-
sophila DGKO (dDGKO) with that of the Drosophila DGK encoded by the rdgA gene (rdgA, accession No. Q09103), Dictyostelium
heavy chain myosin kinase (HCMK, accession No. A46136) and three mammalian diacylglycerol kinase isoforms, human DGKO
(hDGKO, accession No. U49379), hamster DGKR (DGKR, accession No. Q64398) and human DGKK (hDGKK, accession No.
P23743). Amino acids that are identical between DGKO and one or more of the other proteins are shaded. The positions of conserva-
tive cysteine residues in the zinc ¢nger-like motifs C1 are marked with an asterisk. The ATP binding motif in the catalytic domain is
designated with circles. The alignment was made by use of the computer program MegAlign from DNA STAR.
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Finally, DGKO transcripts are present in salivary
glands, a known endoreplicative organ (Fig. 6F).
No further mitotic divisions occur in the midgut ep-
ithelium after fusion of anterior and posterior midgut
primordia. The DGKO expression in midgut contin-
ues at stages 15 and 16 (Fig. 6E^G). At stage 17,
when the midgut becomes more convoluted, staining
extends through the entire midgut (Fig. 6H). In con-
trast, amnioserosa cells which arrested in G2, are
completely unstained (Fig. 6C,D).
In third instar larvae, no obvious correlation be-
tween the pattern of DGKO expression and the cell
cycle is observed. In eye antennal discs, DGKO tran-
scripts are present at high level in a ring correspond-
ing to future peripheral antennal segments and in
lateral edges of the eye disc (Fig. 5B). In the larval
central nervous system, staining is seen in two strips
around the optic lobe as well as in several groups of
cells in the central brain and thoracic neuroblasts,
while mushroom bodies and abdominal neuroblasts
are unstained (Fig. 5D). In the adult testis, DGKO
mRNA is detected at the tip of the testis in primary
spermatocytes (Fig. 5C), implying the involvement of
DGKO at the beginning of the di¡erentiation pro-
gram.
Fig. 4. Northern analysis of the DGKO mRNA. Blot hybridization containing total RNA isolated from £ies segregating for ox1, oxrev
and ox107ÿ2 with antisense RNA probes for DGKO. The positions of molecular weight markers are given on the right. Loading control
(rRNA) is shown below.
Fig. 5. Distribution of DGKO transcripts in Drosophila repro-
ductive organs and primordia. (A) DGKO transcripts are ¢rst
found in nurse cells at late stages of oogenesis. (B) Lateral
edges of the eye imaginal disc and outer ring of the antennal
imaginal disc exhibit a strong staining. (C) In testis, the tran-
scripts are detected in primary spermatocytes. (D) In the brain,
the expression of DGKO appears around the optic lobes (arrow),
in thoracic neuroblasts and in midbrain.
BBAMCR 14744 17-4-01
M.V. Frolov et al. / Biochimica et Biophysica Acta 1538 (2001) 339^352 347
3.3. De¢ciency of DG kinase activity in
ox107ÿ2 mutants
To further establish a link between DGKO gene
and DG kinase activity, a DG kinase assay was per-
formed to determine whether DG kinase activity is
proportional to the dose of DGKO gene. We em-
ployed a mixed-micellar assay to measure DG kinase
activity in homogenates with saturating concentra-
tion of exogenous substrate. To ensure that labeling
of PA occurs via the DG kinase route and endoge-
nous DG does not signi¢cantly contribute to the re-
action, a negative control assay without substrate
was performed in each experiment. Under these con-
ditions, given the linearity of reaction, the amount of
formed labeled PA would re£ect the speci¢c DG ki-
nase activity.
Measurement of DG kinase activity in homoge-
nates prepared from whole £ies did not reveal any
di¡erences in PA labeling when a substrate was
added. However, when testis homogenates were
used, a strong accumulation of labeled PA was ob-
served upon addition of DG, while no labeling of PA
was detected without substrate. Therefore, testes
were chosen as a source of material for further anal-
ysis of DG kinase activity.
The enzyme activity was measured in the case of
deletion of DGKO in the null allele ox107ÿ2. As a
control, the oxrev allele was used in parallel. The
mutation results in a 2-fold reduction in DG kinase
activity compared to that of the control. Thus, the
testis-speci¢c DG kinase activity is directly propor-
Fig. 7. Diacylglycerol kinase activity associated with the DGKO
gene. Autoradiographs of the region of a thin layer chromatog-
raphy plate corresponding to PA show an e¡ect of the dose of
DGKO on the testis-speci¢c diacylglycerol kinase activity. The
activity was assayed in crude extracts from testis of (A) oxrev/
oxrev (+/+) and ox107ÿ2/+ (ox/+) males and (B) oxrev/oxrev (+/+)
and GAL4/P[mw ; UAS-DGKO] (P/+). The revertant is shown
as 100%. The control reaction was performed without substrate
(3DG). The values shown are means of seven experiments in
A.
Fig. 6. DGKO expression pattern in embryogenesis. (A) Expres-
sion in the yolk of early stage 5 embryo. (B) At stage 6, weak
staining in germ band starting elongation. (C) At stage 9, stain-
ing reveals ectodermal and mesodermal/endodermal cells which
are in interphase before ¢rst postblastoderm mitosis. Staining
of anterior and posterior midgut primordia (am and pm in D,
stage 13), hindgut and Malpighian tubules (h and mt in E,F,
both embryos of stage 15) correlates with the start of endorepli-
cation. Salivary glands (sg) are depicted by staining in F. (G)
Three constrictions (thin arrows) from which di¡erent parts of
the midgut will arise are demarked by staining. Maximum
staining (thick arrow) is observed at the base of the ¢rst midgut
subdivision, where the gastric caeca develop. (F) Further in de-
velopment, the four midgut subdivisions shrink resulting in the
larval midgut. Some staining is also observed in the somatic
musculature.
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tional to the dose of functional copies of the DGKO
gene.
As described in the previous section, DGKO is ex-
pressed in larval brain and eye imaginal discs. There-
fore, we measured DG kinase activity in adult head
homogenates. The head-speci¢c DG kinase activity
was about a 100 times higher than that in testis
and no di¡erence between the ox107ÿ2 and oxrev al-
leles was found (data not shown). Presumably, this
activity corresponds to the DGK isoform encoded by
the rdgA gene [29], which would mask the contribu-
tion of DGKO.
3.4. Overexpression of DGKO in E. coli
In order to con¢rm that the product of the DGKO
gene possesses a DG kinase activity, the recombinant
DGKO cDNA (Fig. 1) containing the full-size open
reading frame was cloned into pQE-32. The resulting
plasmid pQE-DGK was overexpressed in E. coli. The
enzyme was obtained from the Ni-NTA column by
elution with the bu¡er containing 150^200 mM imi-
dazole. The lysate derived from the cells transformed
with pQE-DGK revealed a 5^10-fold increase in DG
kinase activity after induction of the expression com-
pared to non-induced cells (Fig. 7) (Fig. 8). In addi-
tion, the construct containing the DGKO cDNA
cloned in an incorrect open reading frame, pQE-c-
DGK, failed to increase DG kinase activity upon
induction.
3.5. DGKO does not modulate total DG levels
Cell stimulation results in transient elevation of
cellular DG levels, which in turn activates PKC. By
metabolizing DG, DGK may control the DG levels
and therefore serve as a modulator of activity of
some PKC isoforms [50]. We asked whether DGKO
attenuates the accumulation of DG and regulates
PKC activity. Total lipids were isolated from testes
of the mutant, ox107ÿ2, and the control, oxrev, males
and DG levels were determined in a quantitative as-
say using DGK from E. coli [47]. No di¡erence be-
tween DG levels in the revertant and that in the mu-
tant was found (Fig. 9). This result was reproducible
in three independent lipid extractions.
3.6. Overexpression of DGKO in vivo
Flies homozygous for the transgene encoding a
full-size open reading frame of DGKO, P[mw ;
UAS-DGKO], under the control of the yeast UAS
were crossed to £ies homozygous for the yeast heat
shock inducible transcriptional activator GAL4. The
progeny of such a cross will inherit both GAL4 and
the DGKO transgene. After induction with heat
shock, GAL4 binds to the UAS and drives the ex-
pression of the cloned cDNA [36]. The progeny,
GAL4/P[mw ; UAS-DGKO], was heat shocked at dif-
Fig. 9. Total diacylglycerol levels in testis are not a¡ected by
halving the dose of the DGKO gene. Total lipids were isolated
from testes of dissected oxrev/oxrev (+/+) and ox107ÿ2/+ (ox/+)
males and total DG levels were determined using the E. coli
DGK method as described [47]. The data are normalized to to-
tal DG levels in the revertant, oxrev/oxrev. Values represent the
means of three independent experiments.
Fig. 8. Expression of the DGKO gene in E. coli. The pQE-DGK
construct containing a full-size open reading frame was ex-
pressed in E. coli and diacylglycerol kinase activity was assayed
before and after induction. As an additional negative control,
diacylglycerol kinase activity was measured in the induced cells
transformed with the construct pQE-c-DGK, which contains
the DGKO cDNA in an incorrect open reading frame. The val-
ues shown are means of three independent measurements.
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ferent developmental stages. The animals expressing
the DGKO transgene at high level do not show any
visible abnormalities, lethality or sterility. Because a
transgene is known to be a¡ected by the chromoso-
mal location, we asked whether the level of DGKO
expression from the transgene is not su⁄cient to
cause a phenotypic e¡ect. The transgene was mobi-
lized by supplying a stable source of transposase, v2-
3 [35], and new transpositions were isolated. Three
di¡erent transgenic lines were generated, which con-
tain the P[mw ; UAS-DGKO] construct at di¡erent
cytological positions. Again, the induction of DGKO
expression in these three lines did not result in any
morphological abnormalities. To con¢rm that a
functional enzyme is produced in transgenic animals,
DG kinase activity was measured in testes homoge-
nates from wild type and GAL4/P[mw ; UAS-DGKO]
£ies. Overexpression of DGKO results in 4-fold induc-
tion of DG activity (Fig. 7B) compared to non-in-
duced animals.
4. Discussion
Diacylglycerol kinase catalyzes the phosphoryla-
tion of diacylglycerol which occupies a central posi-
tion in both lipid biosynthesis and intracellular sig-
naling. An increasing number of DGKs have been
identi¢ed in multicellular organisms over the past
few years, but their biological function in vivo is
not clear. The data establishing the role of DGKs
in cellular signal transduction have been mainly
based upon the use of DGK inhibitors. However, a
drawback of this approach is that the inhibitor may
exert an e¡ect on other enzymes, thus complicating
the interpretation of the phenotype. In addition, not
all DGK isoforms are equally well inhibited [4,25].
The only known physiological consequence of the
loss of DGK activity has been obtained from the
study of the Drosophila rdgA gene: the mutants de-
velop a retinal degeneration within a week after eclo-
sion due to lack of phosphatidic acid [30]. Interest-
ingly, the closely related human DGKS shows a
similar pattern of expression to rdgA and is thought
to be responsible for the genetic disorder retinitis
pigmentosa [24]. Thus, the study of Drosophila
DGK clari¢ed the role of the DGKS isoform in hu-
man. In this report, we present a functional analysis
of a novel Drosophila DGK, a homologue of human
DGKO. The human DGKO has attracted particular
interest due to a proposed key role in initiating the
resynthesis of PI in mammals.
Several lines of evidence strongly argue that the
DGKO gene encodes a functional DGK. First,
DGK activity measured in testis homogenates is di-
rectly proportional to the gene dosage of DGKO.
DGK activity in £ies heterozygous for DGKO is
half of that in revertant £ies. Second, expression of
the DGKO cDNA in E. coli results in an increased
level of DGK activity in cell lysates compared to
non-induced cells. Finally, the predicted amino acid
sequence of DGKO is homologous to the sequences
of other DGKs. Among di¡erent isoforms, Drosophi-
la DGKO is most similar to human DGKO and has
approximately the same size. The Drosophila DGKO
domain structure is common for type III DGK: two
zinc ¢nger-like motifs at the N-terminus, and the C-
terminal portion conserved among all DGK catalytic
domains. To date, the type III class was represented
by human DGKO, which shows a marked substrate
preference toward DG with an unsaturated fatty acid
residue, arachidonoyl, at the sn-2 position [25]. Se-
quence comparison of human and Drosophila iso-
forms revealed that the ¢rst zinc ¢nger-like domain
presented in both proteins is unique among DGKs.
In PKC, the zinc ¢nger-like motifs mediate binding
of DG [11].
To date, three Drosophila DGK genes have been
isolated. One gene, rdgA, encodes an eye-speci¢c
DGK [30]. This DGK has two cysteine-rich motifs,
a catalytic domain and four ankyrin repeats [30] and
is most similar to DGKS [24]. The expression of the
rdgA gene is exclusively restricted to the adult retina.
Another Drosophila DGK also shows an abundant
expression in the retina [51]. In addition, it is ex-
pressed in late embryos in each segment of the ven-
tral nerve cord. Therefore, this DGK was proposed
to function in nervous system development [51]. In
this respect, it is noteworthy that DGKO expression is
not entirely restricted to a particular developmental
stage, primordia or organ. On the contrary, we ob-
served the DGKO transcripts in each examined organ
or primordia throughout development. This suggests
a possible universal function of DGKO in general cel-
lular processes. In embryogenesis, however, its ex-
pression is mainly limited to the cells being in
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S-phase or to endoreplicative cells, which have
undergone several rounds of replication without cell
division. It is interesting that exogenous PA has been
reported to possess signi¢cant mitogenic activity
[8,10]. Addition of PA results in stimulation of
DNA synthesis in cultured cortical astrocytes [52]
and quiescent ¢broblasts [53]. Based upon the pref-
erential expression of DGKO in the cell during S-
phase, one can suggest that DGKO might increase
the PA level in the cell, which is followed by stim-
ulation of DNA synthesis. However, DGKO is un-
likely to have a role in the transition of the cell
from G1- to S-phase. Indeed, the overexpression of
the DGKO transgene does not give rise to develop-
mental defects one would expect to observe if ectopic
S-phases were induced.
One of the functions attributed to DGK is termi-
nation of the DG signal derived from PI breakdown
and consequently attenuation of PKC activity [4].
Generation of a DGKO null allele allowed us to di-
rectly address the issue whether a change in DGKO
expression is followed by a change of DG levels and
PKC activation. We observed a 2-fold reduction of
testis-speci¢c DGK activity in £ies with one wild-
type copy of DGKO, indicating that this activity is
entirely determined by the DGKO gene. In contrast,
total DG levels were not a¡ected in the DGKO het-
erozygous £ies; therefore, PKC activity is unlikely to
be a¡ected in the mutants. Indeed, there are three
PKC genes in Drosophila and their expression is lim-
ited to the head [54,55]. These data are consistent
with a biochemically measured distribution of PKC
activity between the head and the body: the head
retains almost all PKC activity while less than 5%
is present in the body [56]. We also did not detect
any signi¢cant Ca2/DG-dependent PKC activity in
testis in the case of wild-type £ies. Neither was the
distribution of PKC activity between membrane (ac-
tivated PKC) and cytosol (non-activated PKC) frac-
tions altered in mutants or in GAL4/P[mw ; UAS-
DGKO] transgenic £ies (our unpublished results).
Thus, it seems unlikely that the deletion of DGKO
results in hyperactivation of PKC. Application of a
biochemical approach together with further genetic
analysis of both the null allele of DGKO and the
DGKO transgene would be useful to further study
the DGKO function in vivo.
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